Ildiko Toma1, Michael Qian2, Jaehoon Chung1, Yongquan Gong3, Rajesh Dash1, Robert C. Robbins4, Philip Harnish5, Phillip C. Yang1
1Medicine/Cardiovascular Medicine, Stanford University, Stanford, CA, United States; 2University of California, Berkeley, Berkeley, CA, United States; 3Radiology, Stanford University, Stanford, CA, United States; 4Cardiothoracic Surgery - Adult Cardiac Surgery, Stanford University, Stanford, CA, United States; 5Eagle Vision Pharmaceutical Corp., United States
Delayed enhancement MRI (DEMRI) identifies non-viable myocardium, but is non-specific and may overestimate nonviable territory. Manganese enhanced MRI (MEMRI) signal identifies manganese in viable cells. We performed dual-contrast myocardial assessment, combining DEMRI and MEMRI in a diabetic murine acute infarct model to characterize border zone viability in vivo. MEMRI demonstrated smaller scar volume and percentage compared to DEMRI. Dual-contrast MEMRI-DEMRI may identify at-risk but viable myocardial cells within transmural DEMRI regions.